|
DE3883899T3
(de)
|
1987-03-18 |
1999-04-22 |
Sb2, Inc., Danville, Calif. |
Geänderte antikörper.
|
|
JP2877509B2
(ja)
|
1989-05-19 |
1999-03-31 |
アムジエン・インコーポレーテツド |
メタロプロテイナーゼ阻害剤
|
|
US5885794A
(en)
|
1991-05-10 |
1999-03-23 |
The Salk Institute For Biological Studies |
Recombinant production of vertebrate activin receptor polypeptides and identification of receptor DNAs in the activin/TGF-β superfamily
|
|
US6891082B2
(en)
|
1997-08-01 |
2005-05-10 |
The Johns Hopkins University School Of Medicine |
Transgenic non-human animals expressing a truncated activintype II receptor
|
|
US6656475B1
(en)
|
1997-08-01 |
2003-12-02 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
|
|
DE60027135T2
(de)
|
1999-01-21 |
2007-01-11 |
Metamorphix, Inc. |
Inhibitoren für wachstumdifferenzierungsfaktor und ihre anwendungen
|
|
JP4487376B2
(ja)
|
2000-03-31 |
2010-06-23 |
味の素株式会社 |
腎疾患治療剤
|
|
CN1330664C
(zh)
|
2001-03-07 |
2007-08-08 |
默克专利有限公司 |
用于含杂合同种型抗体部分的蛋白质的表达技术
|
|
AU2012204098B2
(en)
|
2001-04-24 |
2014-05-15 |
The Johns Hopkins University |
Use of follistatin to increase muscle mass
|
|
US20040223966A1
(en)
|
2002-10-25 |
2004-11-11 |
Wolfman Neil M. |
ActRIIB fusion polypeptides and uses therefor
|
|
JP5110877B2
(ja)
|
2003-06-02 |
2012-12-26 |
ワイス・エルエルシー |
神経筋障害を処置するための、コルチコステロイドと組み合わせたミオスタチン（ｇｄｆ８）インヒビターの使用
|
|
EP1682584B1
(en)
|
2003-11-13 |
2013-04-17 |
Hanmi Science Co., Ltd. |
A pharmaceutical composition comprising an immunoglobulin fc region as a carrier
|
|
EP1771470B1
(en)
*
|
2004-07-23 |
2013-06-26 |
Acceleron Pharma Inc. |
Actrii receptor polypeptides, methods and compositions
|
|
AU2015200950B2
(en)
|
2004-07-23 |
2017-04-27 |
Acceleron Pharma Inc. |
ActRII receptor polypeptides, methods and compositions
|
|
EP1778275A2
(en)
|
2004-08-12 |
2007-05-02 |
Wyeth |
Combination therapy for diabetes, obesity, and cardiovascular diseases using gdf-8 inhibitors
|
|
US8067562B2
(en)
|
2005-11-01 |
2011-11-29 |
Amgen Inc. |
Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
|
|
US9844528B2
(en)
|
2006-08-24 |
2017-12-19 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
|
US20100028332A1
(en)
|
2006-12-18 |
2010-02-04 |
Acceleron Pharma Inc. |
Antagonists of actriib and uses for increasing red blood cell levels
|
|
EP2468290B1
(en)
|
2006-12-18 |
2015-04-01 |
Acceleron Pharma, Inc. |
Activin-ActRII Antagonists for use in treating anemia
|
|
TWI782836B
(zh)
|
2007-02-02 |
2022-11-01 |
美商艾瑟勒朗法瑪公司 |
衍生自ActRIIB的變體與其用途
|
|
US7947646B2
(en)
*
|
2007-03-06 |
2011-05-24 |
Amgen Inc. |
Variant activin receptor polypeptides
|
|
WO2013106175A1
(en)
|
2011-12-19 |
2013-07-18 |
Amgen Inc. |
Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof
|
|
US8501678B2
(en)
*
|
2007-03-06 |
2013-08-06 |
Atara Biotherapeutics, Inc. |
Variant activin receptor polypeptides and uses thereof
|
|
WO2009038745A1
(en)
|
2007-09-18 |
2009-03-26 |
Acceleron Pharma Inc. |
Activin-actriia antagonists and uses for decreasing or inhibiting fsh secretion
|
|
PE20091163A1
(es)
|
2007-11-01 |
2009-08-09 |
Wyeth Corp |
Anticuerpos para gdf8
|
|
US20100015144A1
(en)
|
2008-06-26 |
2010-01-21 |
Acceleron Pharma Inc. |
Methods for dosing an activin-actriia antagonist and monitoring of treated patients
|
|
JP5773868B2
(ja)
|
2008-06-26 |
2015-09-02 |
アクセルロン ファーマ， インコーポレイテッド |
アクチビン−ＡｃｔＲＩＩａのアンタゴニストおよび赤血球レベルを高めるためのその使用
|
|
US8216997B2
(en)
*
|
2008-08-14 |
2012-07-10 |
Acceleron Pharma, Inc. |
Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
|
|
US8058229B2
(en)
|
2008-08-14 |
2011-11-15 |
Acceleron Pharma Inc. |
Method of increasing red blood cell levels or treating anemia in a patient
|
|
MY159483A
(en)
|
2008-11-26 |
2017-01-13 |
Amgen Inc |
Variants of activin iib receptor polypeptides and uses thereof
|
|
AU2010204985A1
(en)
|
2009-01-13 |
2011-08-04 |
Acceleron Pharma Inc. |
Methods for increasing adiponectin
|
|
HUE035240T2
(hu)
|
2009-04-27 |
2018-05-02 |
Novartis Ag |
Készítmények és eljárások az izomerõ növelésére
|
|
CN102482339B
(zh)
|
2009-06-08 |
2015-06-17 |
阿塞勒隆制药公司 |
用于增加产热脂肪细胞的方法
|
|
CN107267520A
(zh)
*
|
2009-06-12 |
2017-10-20 |
阿塞勒隆制药公司 |
截短的actriib‑fc融合蛋白
|
|
CN113171442B
(zh)
|
2009-08-13 |
2024-11-15 |
阿塞勒隆制药公司 |
Gdf捕获物和促红细胞生成素受体激活剂联合应用以增加红细胞水平
|
|
MX340451B
(es)
*
|
2009-09-09 |
2016-07-08 |
Acceleron Pharma Inc |
Antagonistas de actriib y dosificacion y usos de los mismos.
|
|
JP5836961B2
(ja)
|
2009-11-03 |
2015-12-24 |
アクセルロン ファーマ， インコーポレイテッド |
脂肪肝疾患を処置するための方法
|
|
US8710016B2
(en)
|
2009-11-17 |
2014-04-29 |
Acceleron Pharma, Inc. |
ActRIIB proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
|
|
US20110268736A1
(en)
|
2010-04-30 |
2011-11-03 |
Children's Medical Center Corporation |
Method for treating congenital myopathy
|
|
WO2012027065A2
(en)
|
2010-08-27 |
2012-03-01 |
Celgene Corporation |
Combination therapy for treatment of disease
|
|
DK3520805T3
(da)
|
2011-10-17 |
2021-04-19 |
Acceleron Pharma Inc |
Sammensætninger til behandling af myelofibrose
|
|
US8765385B2
(en)
|
2011-10-27 |
2014-07-01 |
Ravindra Kumar |
Method of detection of neutralizing anti-actriib antibodies
|
|
US8871209B2
(en)
|
2011-11-14 |
2014-10-28 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or Activin A
|
|
GR1007832B
(el)
*
|
2011-11-21 |
2013-02-14 |
Ιδρυμα Ιατροβιολογικων Ερευνων Ακαδημιας Αθηνων, |
Αδρανοποιητες της ακτιβινης και χρηση τους για την θεραπεια ασθενειων που σχετιζονται με παρεκκλινουσα ενεργοποιηση της "αμυντικης αποκρισης του ξενιστη"
|
|
US9809636B2
(en)
|
2012-04-06 |
2017-11-07 |
Acceleron Pharma Inc. |
Methods for increasing red blood cell levels comprising administering BMP9
|
|
WO2014066486A2
(en)
|
2012-10-24 |
2014-05-01 |
Celgene Corporation |
Biomarker for use in treating anemia
|
|
AU2013337677B2
(en)
|
2012-11-02 |
2018-06-28 |
Celgene Corporation |
Activin-ActRII antagonists and uses for treating bone and other disorders
|
|
SG11201505960VA
(en)
|
2013-02-01 |
2015-08-28 |
Santa Maria Biotherapeutics Inc |
Administration of an anti-activin-a compound to a subject
|
|
US20140220033A1
(en)
|
2013-02-01 |
2014-08-07 |
Santa Maria Biotherapeutics, Inc. |
Administration of an Anti-Activin-A Compound to a Subject
|
|
KR20160127148A
(ko)
|
2014-03-21 |
2016-11-02 |
악셀레론 파마 인코포레이티드 |
액티빈 b 및/또는 gdf11을 억제함으로써 적혈 혈액 세포 수준을 증가시키고 비효율적인 적혈구 생성을 치료하는 방법
|
|
EP3131931B1
(en)
|
2014-04-18 |
2020-10-21 |
Acceleron Pharma Inc. |
Methods for increasing red blood cell levels and treating sickle-cell disease
|
|
CA2952231A1
(en)
|
2014-06-13 |
2015-12-17 |
Santa Maria Biotherapeutics, Inc. |
Formulated receptor polypeptides and related methods
|
|
BR122023023170A2
(pt)
|
2014-06-13 |
2024-02-20 |
Acceleron Pharma Inc. |
Uso de um antagonista de actrii no tratamento ou prevenção de úlcera cutânea associada com beta-talassemia
|
|
US20160075772A1
(en)
|
2014-09-12 |
2016-03-17 |
Regeneron Pharmaceuticals, Inc. |
Treatment of Fibrodysplasia Ossificans Progressiva
|
|
CN107533040B
(zh)
|
2014-12-03 |
2022-03-29 |
细胞基因公司 |
激活素-actrii拮抗剂及用于治疗贫血症的用途
|
|
MA41919A
(fr)
*
|
2015-04-06 |
2018-02-13 |
Acceleron Pharma Inc |
Hétéromultimères alk4:actriib et leurs utilisations
|
|
JP7055636B2
(ja)
|
2015-04-06 |
2022-04-18 |
アクセルロン ファーマ インコーポレイテッド |
ＡＬＫ７：ＡｃｔＲＩＩＢヘテロ多量体およびその使用
|
|
SMT202100294T1
(it)
*
|
2015-04-22 |
2021-07-12 |
Biogen Ma Inc |
Proteine trappola del liganto acriib ibride innovative per il trattamento di patologie da deperimento muscolare
|
|
CA2996996A1
(en)
|
2015-08-31 |
2017-03-09 |
National Research Council Of Canada |
Tgf-.beta.-receptor ectodomain fusion molecules and uses thereof
|
|
EP3370754A4
(en)
|
2015-11-04 |
2019-10-23 |
Acceleron Pharma Inc. |
METHOD FOR INCREASING ERYTHROCYTE CONCENTRATION AND TREATMENT OF INEFFICIENT ERYTHROPOIESE
|
|
WO2017091706A1
(en)
|
2015-11-23 |
2017-06-01 |
Acceleron Pharma Inc. |
Methods for treating eye disorders
|
|
WO2017192847A1
(en)
*
|
2016-05-04 |
2017-11-09 |
University Of Cincinnati |
Female fertility therapies
|
|
IL301468A
(en)
|
2016-06-13 |
2023-05-01 |
Scholar Rock Inc |
Use of myostatin inhibitors and combination therapies
|
|
KR102761094B1
(ko)
*
|
2016-10-05 |
2025-02-03 |
악셀레론 파마 인코포레이티드 |
변이체 actriib 단백질 및 이의 용도
|
|
JOP20190085A1
(ar)
|
2016-10-20 |
2019-04-17 |
Biogen Ma Inc |
طرق علاج الضمور العضلي ومرض العظام باستخدام بروتينات احتجاز مركب ترابطي actriib هجين حديثة
|
|
CN120535607A
(zh)
*
|
2018-01-12 |
2025-08-26 |
科乐斯疗法公司 |
激活素受体iib型变体及其使用方法
|